NCT04939272 2025-05-01Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell LymphomaCity of Hope Medical CenterPhase 1/2 Active not recruiting8 enrolled
NCT03877055 2022-12-14A Study of Copanlisib and Ibrutinib in Mantle Cell LymphomaMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed8 enrolled 7 charts
NCT02455297 2017-10-02Phase IIa Study of Copanlisib in Relapsed or Refractory Mantle Cell Lymphoma (MCL)BayerPhase 2 Terminated4 enrolled